Health Sciences and Affiliated Teaching Hospitals Research Ethics Board

 Tools for Research at Queen's (TRAQ) Portal Sign-On


We are currently experiencing a high volume of ethics submissions and are prioritizing the review of COVID-19 related research. Review timelines are ~ 8-12 weeks for HSREB.

We recommend your application is submitted to the REB as early as possible.

Thanks for your patience.

If you have questions related to your submission please contact

Queen's University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSREB)


The Principal of Queen's University has invested in the Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSREB) the authority to review proposed research involving human participants that are being conducted under the auspices of Queen's University. HSREB primarily reviews health science research, including all research being conducted at the affiliated teaching hospitals (Kingston Health Sciences Centre (KGH and HDH Sites), Providence Care Centre (PCC) and Ongwanada. GREB primarily conducts reviews in the areas of humanities, social science, science, engineering, and administrative research. The HSREB is also a Clinical Trials Ontario (CTO)  Qualified REB. 

Queen's Federalwide Assurance Number:  FWA00004184. HSREB IRB Number: IRB00001173.

Communication Bulletin

View communication bulletin

HSREB Membership

View membership

HSREB Meeting Schedule

View schedule

In-Person Human Participant Research

Restrictions are in place for in-person research. The process to start or resume in-person research can be found on the VPR website and includes 3 key steps. View Human Participant Research Guidelines and SOP

  • Any previously approved in-person human participant research activity taking place in KFL&A only, and involving participants from KFL&A only, may resume
  • In-Person research involving human participants from outside KFL&A continues to be suspended with the following exceptions:
    • COVID-19 Research
    • Study involves in-person research where the participant is receiving a service that would be delivered/received regardless of the research (e.g., medical treatment)
    • Researchers currently in other regions or countries conducting approved in-person research, may continue, as long as they follow all applicable local public health directives and safety measures
    • Contact your Associate Dean of Research should you be unclear whether your human participant study can continue
  • New requests for in-person human participant research will be reviewed and approved by the central Research Response Team via your Associate Dean of Research

Additional clarification on COVID-19 spread and risk of infection is provided by Queen’s University and our Public Health partners and are continuously being re-assessed. Visit for the most up-to-date information.

Please feel free to contact Jennifer Couture, Manager, Research Ethics Compliance, if you have any questions related to conducting in-person research.

  Virtual Research Guidelines

HSREB Departures from Standard Operating Procedures (Note to File)


SOP # Title
101 Authority and Purpose (PDF 323 KB)
102 Research Activities Requiring HSREB Review  (PDF 103 KB)
103 Training and Education (PDF 53 KB)
104 Management of HSREB Office Personnel (PDF 79 KB)
105A  Conflicts of Interest – HSREB Members and HSREB Office Personnel (PDF 488 KB)
105B Conflicts of Interest – Researcher (PDF 125 KB)
105C Conflicts of Interest – Queen’s University (PDF 113 KB)
106 Signatory Authority (PDF 130 KB)
107 Use and Disclosure of Personal Information (PDF 114 KB)
108 Standard Operating Procedures Maintenance (PDF 127 KB)


SOP # Title
201 Composition of the HSREB (PDF 110 KB)
202 Management of HSREB Membership (PDF 145 KB)
203 Duties of HSREB Members (PDF 131 KB)
204 HSREB Office Personnel Serving as HSREB Members (PDF 127 KB)


SOP # Title
301 HSREB Submission Requirements and Administrative Review (PDF 106 KB)
302 HSREB Meeting Administration (PDF 363 KB)
303 Document Management (PDF 113 KB)


SOP # Title
401 Delegated Review (PDF 105 KB)
402 HSREB Review Decisions (PDF 368 KB)
403 Initial Review - Criteria for HSREB Ethical Clearance (PDF 163 KB)
404 HSREB Amendment Reporting (PDF 259 KB)
405 Renewal of Ethics Clearance (PDF 538 KB)
406 Research Completion (PDF 93 KB)
407 Suspension or Termination of HSREB Ethics Clearance (PDF 243 KB)
408 HSREB Protocol Deviation Reporting (PDF 265 KB)
409 Research Requiring Federalwide Assurance (PDF 350 KB)
410 HSREB Reporting Adverse Events (PDF 329 KB)


SOP # Title
501 HSREB Review During Publicly Declared Emergencies (PDF 130 KB)
502 HSREB Review of Biological and Reproductive Materials (PDF 1331 KB) 
503 HSREB Review of Human Genetic Research (PDF 103 KB)


SOP # Title
601 Communication Researcher (PDF 102 KB)
602 Research Communication (PDF 106 KB)


SOP # Title
701 Informed Consent Form Requirements and Documentation (PDF 123 KB)


SOP # Title
801 Researcher Qualifications and Responsibilities (PDF 112 KB)


SOP # Title
901 External Inspections or Audits (PDF 120 KB)
902 Quality Assurance Review Program (PDF 193 KB)
903 Non-Compliance (PDF 295 KB)


Talk to Us

If you have concerns regarding a research study conducted under the authority of Queen’s University, Kingston General Hospital, Hotel Dieu Hospital, Providence Care Centre, or the Kingston Frontenac Lennox & Addington Health Unit; please contact the Office of Research Ethics.

Our Contact information

Toll-Free Telephone in North America: 1-844-535-2988 Email: HSREB Chair at

Our Role

Your welfare is our concern. If you have any ethics concerns or complaints about a research study, please contact the HSREB Ethics Office.

What We Will Do

  • We will listen to you and address your concerns,
  • We will respect your confidentiality,
  • We will keep you informed about the progress of the review and its conclusion.

HSREB has the authority to stop a research study until action has been taken to remedy the identified problem

Please note: The Ethics Office is working remotely until further notice.

Name and Title Email Phone Number

Dr. Andrew Winterborn

For Scheduling, please contact  Emma Hamer 613-533-2988

Jennifer Couture
Manager, Research Ethics Compliance

For Scheduling, please contact  Emma Hamer

ext. 78223

Crystal McCracken
Ethics Compliance Advisor

For Scheduling, please contact  Emma Hamer

ext. 75826

Megan Allore
Ethics Coordinator, HSREB


Emma Hamer
Ethics Assistant  


 Having an issue with our website? Report a broken or missing page.

Clinical Trials Ontario

Clinical Trials Ontario improves clinical trials for a better Ontario.

Researchers conducting multi-centre clinical trials involving two or more sites
in Ontario must use Clinical Trials Ontario streamlined ethics review.